Real-time enrollment status for this non-hodgkin lymphoma clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:25 AM UTC
| NCT Number | NCT03888105 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Non-Hodgkin Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 576 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | October 15, 2025 (Oct 15, 2025) |
As of March 2, 2026: Clinical trial NCT03888105 is currently active_not_recruiting participants. This clinical trial study for non-hodgkin lymphoma is not currently accepting new participants at 17 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT03888105 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03888105 was last updated Oct 15, 2025 (October 15, 2025). HelloStudys verifies this status automatically.